Ozurdex Implant Injection

Ozurdex Implant Injection utilizes a proprietary solid-polymer drug delivery system that allows the steroid to reach the retina in concentrations that topical drops cannot achieve. It is a critical intervention for patients who have not responded to anti-VEGF therapies or those who require a long-term solution for intraocular inflammation.

Key Clinical Indications

• Retinal Vein Occlusion (RVO): Treats macular edema resulting from Branch RVO (BRVO) or Central RVO (CRVO).

• Posterior Uveitis: Specifically for non-infectious inflammation affecting the back of the eye.

• Diabetic Macular Edema (DME): Indicated for adult patients who are pseudophakic (have an artificial lens) or those who are not candidates for non-corticosteroid therapy.

Administration & Clinical Safety

1. Professional Use Only: Must be administered via an intravitreal injection by a trained Ophthalmologist or Retina Specialist in a sterile clinical setting.

2. The Applicator: Each Ozurdex kit contains a pre-loaded, single-use, specially designed 22-gauge applicator for precise placement.

3. Biodegradable: The implant is made of a lactic acid/glycolic acid polymer that naturally dissolves; no surgical removal is required.

4. Monitoring: Following injection, patients must be monitored for increased intraocular pressure (IOP) and the development of cataracts, which are known risks of steroid therapy.

5. Storage: Store at controlled room temperature between 15°C and 30°C (59°F to 86°F).